Clinical trial
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment…
NCT00121875 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00121875 |
|---|---|
| Title | Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature |
| Official title | Growth Hormone and Insulin Resistance in Girls With Turner Syndrome or Idiopathic Short Stature |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Turner Syndrome, Idiopathic Short Stature |
| Intervention type | Drug |
| Interventions | somatropin (rDNA) |
| Enrollment | 1 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Jul 21, 2005 |
| Last update posted | Sep 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: